Shortage of GLP-1 receptor agonists and related drugs (Ozempic®, Trulicity®, Victoza®, Mounjaro®)
Press release from the Professional Council of Diabetes Québec For several weeks, Quebec has been affected by a supply problem that began with semaglutide (Ozempic®) injectable pens. This is a worldwide shortage due to the high demand for diabetes and obesity treatment. As a result, intermittent stockouts are expected until April 2024 in Canada for…